Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin Gel Adjunct to Xenograft for Periodontal Defects
NCT06821425Phase 4Completed
- Sponsor
- Ain Shams University
- Start
- Jan 2025
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of Mucomel in periodontitis (2 arms), sponsored by Ain Shams University. Primary endpoint: Radiographic evaluation of the changes in the intrabony defect at 6 months. Started Jan 2025; status: completed.
02
Drugs
Mucomel
03
Conditions
periodontitis
Beyond the preview
Go deeper on NCT06821425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06821425.